Other Bacterial Infections After Hematopoietic Stem Cell or Solid Organ Transplantation

  • Lynne Strasfeld
  • Stephen Dummer


This chapter describes the epidemiology, clinical presentation, diagnosis, and management of infections caused by a diverse group of bacterial pathogens. These include classic opportunistic infections, such as listeriosis or nocardiosis, and also infections that are common in immunocompetent patients but particularly prevalent or morbid in transplant populations, such as Legionella pneumonia and Clostridium difficile infection. Some uncommon bacterial pathogens that have a predilection for patients with impaired immunity such as Mycoplasma hominis and Rhodococcus equi are also discussed. Finally, the chapter touches on some miscellaneous bacterial infections that are important because they may be unanticipated in transplant recipients or present diagnostic or therapeutic challenges.


Transplant Infection Listeria Nocardia Clostridium difficile Rhodococcus Legionella 


  1. 1.
    Lorber B. Listeriosis. Clin Infect Dis. 1997;24(1):1–9. quiz 10–1.CrossRefPubMedGoogle Scholar
  2. 2.
    Schuchat A, Swaminathan B, Broome CV. Epidemiology of human listeriosis. Clin Microbiol Rev. 1991;4(2):169–83.PubMedCentralCrossRefPubMedGoogle Scholar
  3. 3.
    MacGowan AP, Marshall RJ, MacKay IM, Reeves DS. Listeria faecal carriage by renal transplant recipients, haemodialysis patients and patients in general practice: its relation to season, drug therapy, foreign travel, animal exposure and diet. Epidemiol Infect. 1991;106(1):157–66.PubMedCentralCrossRefPubMedGoogle Scholar
  4. 4.
    Swaminathan B, Gerner-Smidt P. The epidemiology of human listeriosis. Microbes Infect. 2007;9(10):1236–43.CrossRefPubMedGoogle Scholar
  5. 5.
    Linnan MJ, Mascola L, Lou XD, Goulet V, May S, Salminen C, et al. Epidemic listeriosis associated with Mexican-style cheese. N Engl J Med. 1988;319(13):823–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Ooi ST, Lorber B. Gastroenteritis due to Listeria monocytogenes. Clin Infect Dis. 2005;40(9):1327–32.CrossRefPubMedGoogle Scholar
  7. 7.
    Centers for Disease C Prevention. Vital signs: Listeria illnesses, deaths, and outbreaks—United States, 2009-2011. Morb Mortal Wkly Rep. 2013;62(22):448–52.Google Scholar
  8. 8.
    Bennion JR, Sorvillo F, Wise ME, Krishna S, Mascola L. Decreasing listeriosis mortality in the United States, 1990-2005. Clin Infect Dis. 2008;47(7):867–74.CrossRefPubMedGoogle Scholar
  9. 9.
    Zenewicz LA, Shen H. Innate and adaptive immune responses to Listeria monocytogenes: a short overview. Microbes Infect. 2007;9(10):1208–15.PubMedCentralCrossRefPubMedGoogle Scholar
  10. 10.
    Chang J, Powles R, Mehta J, Paton N, Treleaven J, Jameson B. Listeriosis in bone marrow transplant recipients: incidence, clinical features, and treatment. Clin Infect Dis. 1995;21(5):1289–90.CrossRefPubMedGoogle Scholar
  11. 11.
    Stamm AM, Dismukes WE, Simmons BP, Cobbs CG, Elliott A, Budrich P, et al. Listeriosis in renal transplant recipients: report of an outbreak and review of 102 cases. Rev Infect Dis. 1982;4(3):665–82.CrossRefPubMedGoogle Scholar
  12. 12.
    Limaye AP, Perkins JD, Kowdley KV. Listeria infection after liver transplantation: report of a case and review of the literature. Am J Gastroenterol. 1998;93(10):1942–4.CrossRefPubMedGoogle Scholar
  13. 13.
    Tseng J, Strasfeld LM, Orloff SL. An unusual presentation of altered mental status after orthotopic liver transplantation: Listeria brain abscess. Transplantation. 2013;95(12):e72–3.CrossRefPubMedGoogle Scholar
  14. 14.
    Goulet V, Hebert M, Hedberg C, Laurent E, Vaillant V, De Valk H, et al. Incidence of listeriosis and related mortality among groups at risk of acquiring listeriosis. Clin Infect Dis. 2012;54(5):652–60.CrossRefPubMedGoogle Scholar
  15. 15.
    Skogberg K, Syrjanen J, Jahkola M, Renkonen OV, Paavonen J, Ahonen J, et al. Clinical presentation and outcome of listeriosis in patients with and without immunosuppressive therapy. Clin Infect Dis. 1992;14(4):815–21.CrossRefPubMedGoogle Scholar
  16. 16.
    Mylonakis E, Hohmann EL, Calderwood SB. Central nervous system infection with Listeria monocytogenes. 33 years’ experience at a general hospital and review of 776 episodes from the literature. Medicine (Baltimore). 1998;77(5):313–36.CrossRefGoogle Scholar
  17. 17.
    Clauss HE, Lorber B. Central nervous system infection with Listeria monocytogenes. Curr Infect Dis Rep. 2008;10(4):300–6.CrossRefPubMedGoogle Scholar
  18. 18.
    Larson CC, Baine WB, Ware AJ, Krejs GJ. Listeria peritonitis diagnosed by laparoscopy. Gastrointest Endosc. 1988;34(4):352–4.CrossRefPubMedGoogle Scholar
  19. 19.
    Vargas V, Aleman C, de Torres I, Castells L, Gavalda J, Margarit C, et al. Listeria monocytogenes-associated acute hepatitis in a liver transplant recipient. Liver. 1998;18(3):213–5.CrossRefPubMedGoogle Scholar
  20. 20.
    Abadie SM, Dalovisio JR, Pankey GA, Cortez LM. Listeria monocytogenes arthritis in a renal transplant recipient. J Infect Dis. 1987;156(2):413–4.CrossRefPubMedGoogle Scholar
  21. 21.
    Algan M, Jonon B, George JL, Lion C, Kessler M, Burdin JC. Listeria monocytogenes endophthalmitis in a renal-transplant patient receiving ciclosporin. Ophthalmologica. 1990;201(1):23–7.CrossRefPubMedGoogle Scholar
  22. 22.
    Avery RK, Barnes DS, Teran JC, Wiedemann HP, Hall G, Wacker T, et al. Listeria monocytogenes tricuspid valve endocarditis with septic pulmonary emboli in a liver transplant recipient. Transpl Infect Dis. 1999;1(4):284–7.CrossRefPubMedGoogle Scholar
  23. 23.
    Edmiston Jr CE, Gordon RC. Evaluation of gentamicin and penicillin as a synergistic combination in experimental murine listeriosis. Antimicrob Agents Chemother. 1979;16(6):862–3.PubMedCentralCrossRefPubMedGoogle Scholar
  24. 24.
    Kim KS. In vitro and in vivo studies of imipenem-cilastatin alone and in combination with gentamicin against Listeria monocytogenes. Antimicrob Agents Chemother. 1986;29(2):289–93.PubMedCentralCrossRefPubMedGoogle Scholar
  25. 25.
    Stepanovic S, Lazarevic G, Jesic M, Kos R. Meropenem therapy failure in Listeria monocytogenes infection. Eur J Clin Microbiol Infect Dis. 2004;23(6):484–6.CrossRefPubMedGoogle Scholar
  26. 26.
    Leiti O, Gross JW, Tuazon CU. Treatment of brain abscess caused by Listeria monocytogenes in a patient with allergy to penicillin and trimethoprim-sulfamethoxazole. Clin Infect Dis. 2005;40(6):907–8.CrossRefPubMedGoogle Scholar
  27. 27.
    Baldassarre JS, Ingerman MJ, Nansteel J, Santoro J. Development of Listeria meningitis during vancomycin therapy: a case report. J Infect Dis. 1991;164(1):221–2.CrossRefPubMedGoogle Scholar
  28. 28.
    Dryden MS, Jones NF, Phillips I. Vancomycin therapy failure in Listeria monocytogenes peritonitis in a patient on continuous ambulatory peritoneal dialysis. J Infect Dis. 1991;164(6):1239.CrossRefPubMedGoogle Scholar
  29. 29.
  30. 30.
    Wilson JP, Turner HR, Kirchner KA, Chapman SW. Nocardial infections in renal transplant recipients. Medicine (Baltimore). 1989;68(1):38–57.CrossRefGoogle Scholar
  31. 31.
    Clark NM, Reid GE. Practice ASTIDCo Nocardia infections in solid organ transplantation. Am J Transplant. 2013;13 Suppl 4:83–92.CrossRefPubMedGoogle Scholar
  32. 32.
    Peleg AY, Husain S, Qureshi ZA, Silveira FP, Sarumi M, Shutt KA, et al. Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study. Clin Infect Dis. 2007;44(10):1307–14.CrossRefPubMedGoogle Scholar
  33. 33.
    van Burik JA, Hackman RC, Nadeem SQ, Hiemenz JW, White MH, Flowers ME, et al. Nocardiosis after bone marrow transplantation: a retrospective study. Clin Infect Dis. 1997;24(6):1154–60.CrossRefPubMedGoogle Scholar
  34. 34.
    Choucino C, Goodman SA, Greer JP, Stein RS, Wolff SN, Dummer JS. Nocardial infections in bone marrow transplant recipients. Clin Infect Dis. 1996;23(5):1012–9.CrossRefPubMedGoogle Scholar
  35. 35.
    Lovett IS, Houang ET, Burge S, Turner-Warwick M, Thompson FD, Harrison AR, et al. An outbreak of Nocardia asteroides infection in a renal transplant unit. Q J Med. 1981;50(198):123–35.PubMedGoogle Scholar
  36. 36.
    Bargehr J, Flors L, Leiva-Salinas C, Flohr TR, Sawyer R, Bonatti H, et al. Nocardiosis in solid-organ transplant recipients: spectrum of imaging findings. Clin Radiol. 2013;68(5):e266–71.CrossRefPubMedGoogle Scholar
  37. 37.
    Poonyagariyagorn HK, Gershman A, Avery R, Minai O, Blazey H, Asamoto K, et al. Challenges in the diagnosis and management of Nocardia infections in lung transplant recipients. Transpl Infect Dis. 2008;10(6):403–8.CrossRefPubMedGoogle Scholar
  38. 38.
    Wallace Jr RJ, Septimus EJ, Williams Jr TW, Conklin RH, Satterwhite TK, Bushby MB, et al. Use of trimethoprim-sulfamethoxazole for treatment of infections due to Nocardia. Rev Infect Dis. 1982;4(2):315–25.CrossRefPubMedGoogle Scholar
  39. 39.
    Simpson GL, Stinson EB, Egger MJ, Remington JS. Nocardial infections in the immunocompromised host: a detailed study in a defined population. Rev Infect Dis. 1981;3(3):492–507.CrossRefPubMedGoogle Scholar
  40. 40.
    Uhde KB, Pathak S, McCullum Jr I, Jannat-Khah DP, Shadomy SV, Dykewicz CA, et al. Antimicrobial-resistant Nocardia isolates, United States, 1995-2004. Clin Infect Dis. 2010;51(12):1445–8.CrossRefPubMedGoogle Scholar
  41. 41.
    Brown-Elliott BA, Biehle J, Conville PS, Cohen S, Saubolle M, Sussland D, et al. Sulfonamide resistance in isolates of Nocardia spp. from a US multicenter survey. J Clin Microbiol. 2012;50(3):670–2.PubMedCentralCrossRefPubMedGoogle Scholar
  42. 42.
    Cercenado E, Marin M, Sanchez-Martinez M, Cuevas O, Martinez-Alarcon J, Bouza E. In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods. Antimicrob Agents Chemother. 2007;51(3):1102–4.CrossRefPubMedGoogle Scholar
  43. 43.
    Brown-Elliott BA, Ward SC, Crist CJ, Mann LB, Wilson RW, Wallace Jr RJ. In vitro activities of linezolid against multiple Nocardia species. Antimicrob Agents Chemother. 2001;45(4):1295–7.PubMedCentralCrossRefPubMedGoogle Scholar
  44. 44.
    Jodlowski TZ, Melnychuk I, Conry J. Linezolid for the treatment of Nocardia spp. infections. Ann Pharmacother. 2007;41(10):1694–9.CrossRefPubMedGoogle Scholar
  45. 45.
    McNeil MM, Brown JM, Georghiou PR, Allworth AM, Blacklock ZM. Infections due to Nocardia transvalensis: clinical spectrum and antimicrobial therapy. Clin Infect Dis. 1992;15(3):453–63.CrossRefPubMedGoogle Scholar
  46. 46.
    Gombert ME, Berkowitz LB, Aulicino TM, duBouchet L. Therapy of pulmonary nocardiosis in immunocompromised mice. Antimicrob Agents Chemother. 1990;34(9):1766–8.PubMedCentralCrossRefPubMedGoogle Scholar
  47. 47.
    Gombert ME, Aulicino TM, duBouchet L, Silverman GE, Sheinbaum WM. Therapy of experimental cerebral nocardiosis with imipenem, amikacin, trimethoprim-sulfamethoxazole, and minocycline. Antimicrob Agents Chemother. 1986;30(2):270–3.PubMedCentralCrossRefPubMedGoogle Scholar
  48. 48.
    Tripodi MF, Durante-Mangoni E, Fortunato R, Cuccurullo S, Mikami Y, Farina C, et al. In vitro activity of multiple antibiotic combinations against Nocardia: relationship with a short-term treatment strategy in heart transplant recipients with pulmonary nocardiosis. Transpl Infect Dis. 2011;13(4):335–43.CrossRefPubMedGoogle Scholar
  49. 49.
    Toporoff B, Rosado LJ, Appleton CP, Sethi GK, Copeland JG. Successful treatment of early infective endocarditis and mediastinitis in a heart transplant recipient. J Heart Lung Transplant. 1994;13(3):546–8.PubMedGoogle Scholar
  50. 50.
    Kalima P, Masterton RG, Roddie PH, Thomas AE. Lactobacillus rhamnosus infection in a child following bone marrow transplant. J Infect. 1996;32(2):165–7.CrossRefPubMedGoogle Scholar
  51. 51.
    Patel R, Cockerill FR, Porayko MK, Osmon DR, Ilstrup DM, Keating MR. Lactobacillemia in liver transplant patients. Clin Infect Dis. 1994;18(2):207–12.CrossRefPubMedGoogle Scholar
  52. 52.
    Jones SD, Fullerton DA, Zamora MR, Badesch DB, Campbell DN, Grover FL. Transmission of Lactobacillus pneumonia by a transplanted lung. Ann Thorac Surg. 1994;58(3):887–9.CrossRefPubMedGoogle Scholar
  53. 53.
    Sherman ME, Albrecht M, DeGirolami PC, Kirkley SA, Wolf B, Eliopoulos GM, et al. An unusual case of splenic abscess and sepsis in an immunocompromised host. Am J Clin Pathol. 1987;88(5):659–62.CrossRefPubMedGoogle Scholar
  54. 54.
    Cannon JP, Lee TA, Bolanos JT, Danziger LH. Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis. 2005;24(1):31–40.CrossRefPubMedGoogle Scholar
  55. 55.
    Antony SJ, Stratton CW, Dummer JS. Lactobacillus bacteremia: description of the clinical course in adult patients without endocarditis. Clin Infect Dis. 1996;23(4):773–8.CrossRefPubMedGoogle Scholar
  56. 56.
    Robin F, Paillard C, Marchandin H, Demeocq F, Bonnet R, Hennequin C. Lactobacillus rhamnosus meningitis following recurrent episodes of bacteremia in a child undergoing allogeneic hematopoietic stem cell transplantation. J Clin Microbiol. 2010;48(11):4317–9.PubMedCentralCrossRefPubMedGoogle Scholar
  57. 57.
    Mehta A, Rangarajan S, Borate U. A cautionary tale for probiotic use in hematopoietic SCT patients-Lactobacillus acidophilus sepsis in a patient with mantle cell lymphoma undergoing hematopoietic SCT. Bone Marrow Transplant. 2013;48(3):461–2.CrossRefPubMedGoogle Scholar
  58. 58.
    Luong ML, Sareyyupoglu B, Nguyen MH, Silveira FP, Shields RK, Potoski BA, et al. Lactobacillus probiotic use in cardiothoracic transplant recipients: a link to invasive Lactobacillus infection? Transpl Infect Dis. 2010;12(6):561–4.CrossRefPubMedGoogle Scholar
  59. 59.
    Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT, et al. Comparative in vitro activities of XRP 2868, pristinamycin, quinupristin-dalfopristin, vancomycin, daptomycin, linezolid, clarithromycin, telithromycin, clindamycin, and ampicillin against anaerobic gram-positive species, actinomycetes, and lactobacilli. Antimicrob Agents Chemother. 2005;49(1):408–13.PubMedCentralCrossRefPubMedGoogle Scholar
  60. 60.
    Prescott JF. Rhodococcus equi: an animal and human pathogen. Clin Microbiol Rev. 1991;4(1):20–34.PubMedCentralCrossRefPubMedGoogle Scholar
  61. 61.
    Weinstock DM, Brown AE. Rhodococcus equi: an emerging pathogen. Clin Infect Dis. 2002;34(10):1379–85.CrossRefPubMedGoogle Scholar
  62. 62.
    Arya B, Hussian S, Hariharan S. Rhodococcus equi pneumonia in a renal transplant patient: a case report and review of literature. Clin Transplant. 2004;18(6):748–52.CrossRefPubMedGoogle Scholar
  63. 63.
    Cronin SM, Abidi MH, Shearer CJ, Chandrasekar PH, Ibrahim RB. Rhodococcus equi lung infection in an allogeneic hematopoietic stem cell transplant recipient. Transpl Infect Dis. 2008;10(1):48–51.CrossRefPubMedGoogle Scholar
  64. 64.
    Munoz P, Burillo A, Palomo J, Rodriguez-Creixems M, Bouza E. Rhodococcus equi infection in transplant recipients: case report and review of the literature. Transplantation. 1998;65(3):449–53.CrossRefPubMedGoogle Scholar
  65. 65.
    Verville TD, Huycke MM, Greenfield RA, Fine DP, Kuhls TL, Slater LN. Rhodococcus equi infections of humans 12 cases and a review of the literature. Medicine (Baltimore). 1994;73(3):119–32.CrossRefGoogle Scholar
  66. 66.
    Perez MG, Vassilev T, Kemmerly SA. Rhodococcus equi infection in transplant recipients: a case of mistaken identity and review of the literature. Transpl Infect Dis. 2002;4(1):52–6.CrossRefPubMedGoogle Scholar
  67. 67.
    Nordmann P, Ronco E. In-vitro antimicrobial susceptibility of Rhodococcus equi. J Antimicrob Chemother. 1992;29(4):383–93.CrossRefPubMedGoogle Scholar
  68. 68.
    McNeil MM, Brown JM. Distribution and antimicrobial susceptibility of Rhodococcus equi from clinical specimens. Eur J Epidemiol. 1992;8(3):437–43.CrossRefPubMedGoogle Scholar
  69. 69.
    Bowersock TL, Salmon SA, Portis ES, Prescott JF, Robison DA, Ford CW, et al. MICs of oxazolidinones for Rhodococcus equi strains isolated from humans and animals. Antimicrob Agents Chemother. 2000;44(5):1367–9.PubMedCentralCrossRefPubMedGoogle Scholar
  70. 70.
    Munoz P, Palomo J, Guinea J, Yanez J, Giannella M, Bouza E. Relapsing Rhodococcus equi infection in a heart transplant recipient successfully treated with long-term linezolid. Diagn Microbiol Infect Dis. 2008;60(2):197–9.CrossRefPubMedGoogle Scholar
  71. 71.
    Menon V, Gottlieb T, Gallagher M, Cheong EL. Persistent Rhodococcus equi infection in a renal transplant patient: case report and review of the literature. Transpl Infect Dis. 2012;14(6):E126–33.CrossRefPubMedGoogle Scholar
  72. 72.
    Ursales A, Klein JA, Beal SG, Koch M, Clement-Kruzel S, Melton LB, et al. Antibiotic failure in a renal transplant patient with Rhodococcus equi infection: an indication for surgical lobectomy. Transpl Infect Dis. 2014;16(6):1019–23.CrossRefPubMedGoogle Scholar
  73. 73.
    Kyne L, Warny M, Qamar A, Kelly CP. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med. 2000;342(6):390–7.CrossRefPubMedGoogle Scholar
  74. 74.
    Paudel S, Zacharioudakis IM, Zervou FN, Ziakas PD, Mylonakis E. Prevalence of Clostridium difficile infection among solid organ transplant recipients: a meta-analysis of published studies. PLoS One. 2015;10(4):e0124483.PubMedCentralCrossRefPubMedGoogle Scholar
  75. 75.
    Alonso CD, Treadway SB, Hanna DB, Huff CA, Neofytos D, Carroll KC, et al. Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2012;54(8):1053–63.PubMedCentralCrossRefPubMedGoogle Scholar
  76. 76.
    Willems L, Porcher R, Lafaurie M, Casin I, Robin M, Xhaard A, et al. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome. Biol Blood Marrow Transplant. 2012;18(8):1295–301.CrossRefPubMedGoogle Scholar
  77. 77.
    Dubberke ER, Reske KA, Srivastava A, Sadhu J, Gatti R, Young RM, et al. Clostridium difficile-associated disease in allogeneic hematopoietic stem-cell transplant recipients: risk associations, protective associations, and outcomes. Clin Transplant. 2010;24(2):192–8.CrossRefPubMedGoogle Scholar
  78. 78.
    Kamboj M, Xiao K, Kaltsas A, Huang YT, Sun J, Chung D, et al. Clostridium difficile infection after allogeneic hematopoietic stem cell transplant: strain diversity and outcomes associated with NAP1/027. Biol Blood Marrow Transplant. 2014;20(10):1626–33.PubMedCentralCrossRefPubMedGoogle Scholar
  79. 79.
    Dallal RM, Harbrecht BG, Boujoukas AJ, Sirio CA, Farkas LM, Lee KK, et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg. 2002;235(3):363–72.PubMedCentralCrossRefPubMedGoogle Scholar
  80. 80.
    Brecher SM, Novak-Weekley SM, Nagy E. Laboratory diagnosis of Clostridium difficile infections: there is light at the end of the colon. Clin Infect Dis. 2013;57(8):1175–81.CrossRefPubMedGoogle Scholar
  81. 81.
    Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013;108(4):478–98. quiz 99.CrossRefPubMedGoogle Scholar
  82. 82.
    Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431–55.CrossRefPubMedGoogle Scholar
  83. 83.
    Louie TJ, Miller MA, Mullane KM, Weiss K, Lentnek A, Golan Y, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011;364(5):422–31.CrossRefPubMedGoogle Scholar
  84. 84.
    Clutter DS, Dubrovskaya Y, Merl MY, Teperman L, Press R, Safdar A. Fidaxomicin versus conventional antimicrobial therapy in 59 recipients of solid organ and hematopoietic stem cell transplantation with Clostridium difficile-associated diarrhea. Antimicrob Agents Chemother. 2013;57(9):4501–5.PubMedCentralCrossRefPubMedGoogle Scholar
  85. 85.
    van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368(5):407–15.CrossRefPubMedGoogle Scholar
  86. 86.
    Kelly CR, Ihunnah C, Fischer M, Khoruts A, Surawicz C, Afzali A, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol. 2014;109(7):1065–71.PubMedCentralCrossRefPubMedGoogle Scholar
  87. 87.
    Mittal C, Miller N, Meighani A, Hart BR, John A, Ramesh M. Fecal microbiota transplant for recurrent Clostridium difficile infection after peripheral autologous stem cell transplant for diffuse large B-cell lymphoma. Bone Marrow Transplant. 2015;50(7):1010.CrossRefPubMedGoogle Scholar
  88. 88.
    Diederen BM. Legionella spp. and Legionnaires’ disease. J Infect. 2008;56(1):1–12.Google Scholar
  89. 89.
    Dowling JN, Pasculle AW, Frola FN, Zaphyr MK, Yee RB. Infections caused by Legionella micdadei and Legionella pneumophila among renal transplant recipients. J Infect Dis. 1984;149(5):703–13.CrossRefPubMedGoogle Scholar
  90. 90.
    Humphreys H, Marshall RJ, Mackay I, Caul EO. Pneumonia due to Legionella bozemanii and Chlamydia psittaci/TWAR following renal transplantation. J Infect. 1992;25(1):67–71.CrossRefPubMedGoogle Scholar
  91. 91.
    Korman TM, Fuller A, Ibrahim J, Kaye D, Bergin P. Fatal Legionella longbeachae infection following heart transplantation. Eur J Clin Microbiol Infect Dis. 1998;17(1):53–5.CrossRefPubMedGoogle Scholar
  92. 92.
    Kirby BD, Snyder KM, Meyer RD, Finegold SM. Legionnaires’ disease: report of sixty-five nosocomially acquired cases of review of the literature. Medicine (Baltimore). 1980;59(3):188–205.CrossRefGoogle Scholar
  93. 93.
    Horbach I, Fehrenbach FJ. Legionellosis in heart transplant recipients. Infection. 1990;18(6):361–3.CrossRefPubMedGoogle Scholar
  94. 94.
    Fraser TG, Zembower TR, Lynch P, Fryer J, Salvalaggio PR, Yeldandi AV, et al. Cavitary Legionella pneumonia in a liver transplant recipient. Transpl Infect Dis. 2004;6(2):77–80.CrossRefPubMedGoogle Scholar
  95. 95.
    Schwebke JR, Hackman R, Bowden R. Pneumonia due to Legionella micdadei in bone marrow transplant recipients. Rev Infect Dis. 1990;12(5):824–8.CrossRefPubMedGoogle Scholar
  96. 96.
    Jacobson KL, Miceli MH, Tarrand JJ, Kontoyiannis DP. Legionella pneumonia in cancer patients. Medicine (Baltimore). 2008;87(3):152–9.CrossRefGoogle Scholar
  97. 97.
    Kool JL, Fiore AE, Kioski CM, Brown EW, Benson RF, Pruckler JM, et al. More than 10 years of unrecognized nosocomial transmission of legionnaires’ disease among transplant patients. Infect Control Hosp Epidemiol. 1998;19(12):898–904.Google Scholar
  98. 98.
    Oren I, Zuckerman T, Avivi I, Finkelstein R, Yigla M, Rowe JM. Nosocomial outbreak of Legionella pneumophila serogroup 3 pneumonia in a new bone marrow transplant unit: evaluation, treatment and control. Bone Marrow Transplant. 2002;30(3):175–9.CrossRefPubMedGoogle Scholar
  99. 99.
    Knirsch CA, Jakob K, Schoonmaker D, Kiehlbauch JA, Wong SJ, Della-Latta P, et al. An outbreak of Legionella micdadei pneumonia in transplant patients: evaluation, molecular epidemiology, and control. Am J Med. 2000;108(4):290–5.CrossRefPubMedGoogle Scholar
  100. 100.
    Stout J, Yu VL, Vickers RM, Zuravleff J, Best M, Brown A, et al. Ubiquitousness of Legionella pneumophila in the water supply of a hospital with endemic Legionnaires’ disease. N Engl J Med. 1982;306(8):466–8.Google Scholar
  101. 101.
    Wadowsky RM, Yee RB, Mezmar L, Wing EJ, Dowling JN. Hot water systems as sources of Legionella pneumophila in hospital and nonhospital plumbing fixtures. Appl Environ Microbiol. 1982;43(5):1104–10.PubMedCentralPubMedGoogle Scholar
  102. 102.
    Garbe PL, Davis BJ, Weisfeld JS, Markowitz L, Miner P, Garrity F, et al. Nosocomial Legionnaires’ disease. Epidemiologic demonstration of cooling towers as a source. JAMA. 1985;254(4):521–4.CrossRefPubMedGoogle Scholar
  103. 103.
    Breiman RF, Cozen W, Fields BS, Mastro TD, Carr SJ, Spika JS, et al. Role of air sampling in investigation of an outbreak of legionnaires’ disease associated with exposure to aerosols from an evaporative condenser. J Infect Dis. 1990;161(6):1257–61.Google Scholar
  104. 104.
    Zuravleff JJ, Yu VL, Shonnard JW, Rihs JD, Best M. Legionella pneumophila contamination of a hospital humidifier. Demonstration of aerosol transmission and subsequent subclinical infection in exposed guinea pigs. Am Rev Respir Dis. 1983;128(4):657–61.PubMedGoogle Scholar
  105. 105.
    Jernigan DB, Hofmann J, Cetron MS, Genese CA, Nuorti JP, Fields BS, et al. Outbreak of Legionnaires’ disease among cruise ship passengers exposed to a contaminated whirlpool spa. Lancet. 1996;347(9000):494–9.CrossRefPubMedGoogle Scholar
  106. 106.
    Palmore TN, Stock F, White M, Bordner M, Michelin A, Bennett JE, et al. A cluster of cases of nosocomial legionnaires disease linked to a contaminated hospital decorative water fountain. Infect Control Hosp Epidemiol. 2009;30(8):764–8.PubMedCentralCrossRefPubMedGoogle Scholar
  107. 107.
    Haupt TE, Heffernan RT, Kazmierczak JJ, Nehls-Lowe H, Rheineck B, Powell C, et al. An outbreak of Legionnaires disease associated with a decorative water wall fountain in a hospital. Infect Control Hosp Epidemiol. 2012;33(2):185–91.CrossRefPubMedGoogle Scholar
  108. 108.
    Muder RR, Yu VL, Parry MF. The radiologic manifestations of Legionella pneumonia. Semin Respir Infect. 1987;2(4):242–54.PubMedGoogle Scholar
  109. 109.
    Meyer R, Rappo U, Glickman M, Seo SK, Sepkowitz K, Eagan J, et al. Legionella jordanis in hematopoietic SCT patients radiographically mimicking invasive mold infection. Bone Marrow Transplant. 2011;46(8):1099–103.CrossRefPubMedGoogle Scholar
  110. 110.
    Padrnos LJ, Blair JE, Kusne S, DiCaudo DJ, Mikhael JR. Cutaneous legionellosis: case report and review of the medical literature. Transpl Infect Dis. 2014;16(2):307–14.CrossRefPubMedGoogle Scholar
  111. 111.
    Guyot S, Goy JJ, Gersbach P, Jaton K, Blanc DS, Zanetti G. Legionella pneumophila aortitis in a heart transplant recipient. Transpl Infect Dis. 2007;9(1):58–9.CrossRefPubMedGoogle Scholar
  112. 112.
    Lowry PW, Tompkins LS. Nosocomial legionellosis: a review of pulmonary and extrapulmonary syndromes. Am J Infect Control. 1993;21(1):21–7.CrossRefPubMedGoogle Scholar
  113. 113.
    Gudiol C, Garcia-Vidal C, Fernandez-Sabe N, Verdaguer R, Llado L, Roca J, et al. Clinical features and outcomes of Legionnaires’ disease in solid organ transplant recipients. Transpl Infect Dis. 2009;11(1):78–82.CrossRefPubMedGoogle Scholar
  114. 114.
    Waldron PR, Martin BA, Ho DY. Mistaken identity: Legionella micdadei appearing as acid-fast bacilli on lung biopsy of a hematopoietic stem cell transplant patient. Transpl Infect Dis. 2015;17(1):89–93.PubMedCentralCrossRefPubMedGoogle Scholar
  115. 115.
    Edelstein PH, Meyer RD, Finegold SM. Laboratory diagnosis of Legionnaires’ disease. Am Rev Respir Dis. 1980;121(2):317–27.PubMedGoogle Scholar
  116. 116.
    Benin AL, Benson RF, Besser RE. Trends in legionnaires disease, 1980-1998: declining mortality and new patterns of diagnosis. Clin Infect Dis. 2002;35(9):1039–46.CrossRefPubMedGoogle Scholar
  117. 117.
    Edelstein PH. Antimicrobial chemotherapy for legionnaires’ disease: a review. Clin Infect Dis. 1995;21 Suppl 3:S265–76.CrossRefPubMedGoogle Scholar
  118. 118.
    Mykietiuk A, Carratala J, Fernandez-Sabe N, Dorca J, Verdaguer R, Manresa F, et al. Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy. Clin Infect Dis. 2005;40(6):794–9.CrossRefPubMedGoogle Scholar
  119. 119.
    Sabria M, Pedro-Botet ML, Gomez J, Roig J, Vilaseca B, Sopena N, et al. Fluoroquinolones vs macrolides in the treatment of Legionnaires disease. Chest. 2005;128(3):1401–5.CrossRefPubMedGoogle Scholar
  120. 120.
    Varner TR, Bookstaver PB, Rudisill CN, Albrecht H. Role of rifampin-based combination therapy for severe community-acquired Legionella pneumophila pneumonia. Ann Pharmacother. 2011;45(7–8):967–76.CrossRefPubMedGoogle Scholar
  121. 121.
    Psarros G, Riddell J, Gandhi T, Kauffman CA, Cinti SK. Bartonella henselae infections in solid organ transplant recipients: report of 5 cases and review of the literature. Medicine (Baltimore). 2012;91(2):111–21.CrossRefGoogle Scholar
  122. 122.
    Moulin C, Kanitakis J, Ranchin B, Chauvet C, Gillet Y, Morelon E, et al. Cutaneous bacillary angiomatosis in renal transplant recipients: report of three new cases and literature review. Transpl Infect Dis. 2012;14(4):403–9.CrossRefPubMedGoogle Scholar
  123. 123.
    Rostad CA, McElroy AK, Hilinski JA, Thompson MP, Drew CP, Denison AM, et al. Bartonella henselae-mediated disease in solid organ transplant recipients: two pediatric cases and a literature review. Transpl Infect Dis. 2012;14(5):E71–81.CrossRefPubMedGoogle Scholar
  124. 124.
    Vassallo C, Ardigo M, Brazzelli V, Zecca M, Locatelli F, Alessandrino PE, et al. Bartonella-related pseudomembranous angiomatous papillomatosis of the oral cavity associated with allogeneic bone marrow transplantation and oral graft-versus-host disease. Br J Dermatol. 2007;157(1):174–8.CrossRefPubMedGoogle Scholar
  125. 125.
    Grabas M, Darrieux L, Potier J, Safa G. Hemophagocytic syndrome as the presenting manifestation of bacillary angiomatosis in a renal transplant recipient. J Am Acad Dermatol. 2012;67(5):e236–7.CrossRefPubMedGoogle Scholar
  126. 126.
    Chaudhry AR, Chaudhry MR, Papadimitriou JC, Drachenberg CB. Bartonella henselae infection-associated vasculitis and crescentic glomerulonephritis leading to renal allograft loss. Transpl Infect Dis. 2015;17(3):411–7.CrossRefPubMedGoogle Scholar
  127. 127.
    Scolfaro C, Mignone F, Gennari F, Alfarano A, Veltri A, Romagnoli R, et al. Possible donor-recipient bartonellosis transmission in a pediatric liver transplant. Transpl Infect Dis. 2008;10(6):431–3.CrossRefPubMedGoogle Scholar
  128. 128.
    Orsag J, Flodr P, Melter O, Tkadlec J, Sternbersky J, Hruby M, et al. Cutaneous bacillary angiomatosis due to Bartonella quintana in a renal transplant recipient. Transpl Int. 2015;28(5):626–31.CrossRefPubMedGoogle Scholar
  129. 129.
    Diederen BM, Vermeulen MJ, Verbakel H, van der Zee A, Bergmans A, Peeters MF. Evaluation of an internally controlled real-time polymerase chain reaction assay targeting the groEL gene for the detection of Bartonella spp. DNA in patients with suspected cat-scratch disease. Eur J Clin Microbiol Infect Dis. 2007;26(9):629–33.CrossRefPubMedGoogle Scholar
  130. 130.
    Margolis B, Kuzu I, Herrmann M, Raible MD, Hsi E, Alkan S. Rapid polymerase chain reaction-based confirmation of cat scratch disease and Bartonella henselae infection. Arch Pathol Lab Med. 2003;127(6):706–10.PubMedGoogle Scholar
  131. 131.
    Bass JW, Freitas BC, Freitas AD, Sisler CL, Chan DS, Vincent JM, et al. Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease. Pediatr Infect Dis J. 1998;17(6):447–52.CrossRefPubMedGoogle Scholar
  132. 132.
    Rolain JM, Brouqui P, Koehler JE, Maguina C, Dolan MJ, Raoult D. Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother. 2004;48(6):1921–33.PubMedCentralCrossRefPubMedGoogle Scholar
  133. 133.
    Avery RK, Michaels MG. Practice ASTIDCo. Strategies for safe living after solid organ transplantation. Am J Transplant. 2013;13 Suppl 4:304–10.CrossRefPubMedGoogle Scholar
  134. 134.
    Gisel JJ, Brumble LM, Johnson MM. Bordetella bronchiseptica pneumonia in a kidney-pancreas transplant patient after exposure to recently vaccinated dogs. Transpl Infect Dis. 2010;12(1):73–6.CrossRefPubMedGoogle Scholar
  135. 135.
    Chauncey JB, Schaberg DR. Interstitial pneumonia caused by Bordetella bronchiseptica in a heart transplant patient. Transplantation. 1990;49(4):817–9.CrossRefPubMedGoogle Scholar
  136. 136.
    Patel AK, Prescott-Focht JA, Kunin JR, Essmyer CE, Rosado-de-Christenson ML. Imaging findings in human Bordetella bronchiseptica pneumonia. J Thorac Imaging. 2011;26(4):W146–9.CrossRefPubMedGoogle Scholar
  137. 137.
    Ner Z, Ross LA, Horn MV, Keens TG, MacLaughlin EF, Starnes VA, et al. Bordetella bronchiseptica infection in pediatric lung transplant recipients. Pediatr Transplant. 2003;7(5):413–7.CrossRefPubMedGoogle Scholar
  138. 138.
    Goldberg JD, Kamboj M, Ford R, Kiehn TE, Gilhuley K, Perales MA. “Kennel cough” in a patient following allogeneic hematopoietic stem cell transplant. Bone Marrow Transplant. 2009;44(6):381–2.CrossRefPubMedGoogle Scholar
  139. 139.
    Huebner ES, Christman B, Dummer S, Tang YW, Goodman S. Hospital-acquired Bordetella bronchiseptica infection following hematopoietic stem cell transplantation. J Clin Microbiol. 2006;44(7):2581–3.PubMedCentralCrossRefPubMedGoogle Scholar
  140. 140.
    Choy KW, Wulffraat NM, Wolfs TF, Geelen SP, Kraaijeveld CA, Fleer A. Bordetella bronchiseptica respiratory infection in a child after bone marrow transplantation. Pediatr Infect Dis J. 1999;18(5):481–3.CrossRefPubMedGoogle Scholar
  141. 141.
    McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med. 2010;362(17):1597–604.CrossRefPubMedGoogle Scholar
  142. 142.
    Davenport A, Shallcross TM, Crabtree JE, Davison AM, Will EJ, Heatley RV. Prevalence of Helicobacter pylori in patients with end-stage renal failure and renal transplant recipients. Nephron. 1991;59(4):597–601.CrossRefPubMedGoogle Scholar
  143. 143.
    Teenan RP, Burgoyne M, Brown IL, Murray WR. Helicobacter pylori in renal transplant recipients. Transplantation. 1993;56(1):100–3.CrossRefPubMedGoogle Scholar
  144. 144.
    Dummer JS, Perez-Perez GI, Breinig MK, Lee A, Wolff SN, Kormos R, et al. Seroepidemiology of Helicobacter pylori infection in heart transplant recipients. Clin Infect Dis. 1995;21(5):1303–5.CrossRefPubMedGoogle Scholar
  145. 145.
    Rudi J, Engler S, Theilmann L, Otto G, Stremmel W. Prevalence of serum antibodies to Helicobacter pylori and to CagA protein in liver transplant recipients. Am J Gastroenterol. 1997;92(9):1492–5.PubMedGoogle Scholar
  146. 146.
    Sarkio S, Rautelin H, Halme L. The course of Helicobacter pylori infection in kidney transplantation patients. Scand J Gastroenterol. 2003;38(1):20–6.CrossRefPubMedGoogle Scholar
  147. 147.
    Tobin A, Hackman R, McDonald G. H. pylori infection in the immunocompromised host: a prospective study of 276 patients. Ir J Med Sci. 1992;161:S64–5.Google Scholar
  148. 148.
    Castagnola E, Calvillo M, Gigliotti AR, Fioredda F, Hanau G, Caviglia I, et al. Helicobacter pylori as cause of gastrointestinal disease in children with hemato-oncologic diseases. Pediatr Blood Cancer. 2006;47(1):89–91.CrossRefPubMedGoogle Scholar
  149. 149.
    Shehab TM, Hsi ED, Poterucha JJ, Gunaratnam NT, Fontana RJ. Helicobacter pylori-associated gastric MALT lymphoma in liver transplant recipients. Transplantation. 2001;71(8):1172–5.CrossRefPubMedGoogle Scholar
  150. 150.
    Aull MJ, Buell JF, Peddi VR, Trofe J, Beebe TM, Hanaway MJ, et al. MALToma: a Helicobacter pylori-associated malignancy in transplant patients: a report from the Israel Penn International Transplant Tumor Registry with a review of published literature. Transplantation. 2003;75(2):225–8.CrossRefPubMedGoogle Scholar
  151. 151.
    Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17(4):697–728. table of contents.PubMedCentralCrossRefPubMedGoogle Scholar
  152. 152.
    Taylor-Robinson D. Infections due to species of Mycoplasma and Ureaplasma: an update. Clin Infect Dis. 1996;23(4):671–82. quiz 83-4.CrossRefPubMedGoogle Scholar
  153. 153.
    Clyde Jr WA. Clinical overview of typical Mycoplasma pneumoniae infections. Clin Infect Dis. 1993;17 Suppl 1:S32–6.PubMedGoogle Scholar
  154. 154.
    Koskiniemi M. CNS manifestations associated with Mycoplasma pneumoniae infections: summary of cases at the University of Helsinki and review. Clin Infect Dis. 1993;17 Suppl 1:S52–7.CrossRefPubMedGoogle Scholar
  155. 155.
    O’Sullivan MV, Isbel NM, Johnson DW, Rencken K, Byrne S, Graham MM, et al. Disseminated pyogenic Mycoplasma pneumoniae infection in a renal transplant recipient, detected by broad-range polymerase chain reaction. Clin Infect Dis. 2004;39(9):e98–9.CrossRefPubMedGoogle Scholar
  156. 156.
    Birch J, Chamlin S, Duerst R, Jacobsohn D. Mycoplasma pneumoniae and atypical Stevens-Johnson syndrome in a hematopoietic stem cell transplant recipient. Pediatr Blood Cancer. 2008;50(6):1278–9.CrossRefPubMedGoogle Scholar
  157. 157.
    Tomaino J, Keegan T, Miloh T, Kerkar N, Mercer S, Birge M, et al. Stevens-Johnson syndrome after Mycoplasma pneumonia infection in pediatric post-liver transplant recipient: case report and review of the literature. Pediatr Transplant. 2012;16(3):E74–7.CrossRefPubMedGoogle Scholar
  158. 158.
    Schwerk N, Hartmann C, Baumann U, Pape L, Ehrich JH, Hansen G. Chronic Mycoplasma pneumoniae infection in a child after renal transplantation. Pediatr Transplant. 2010;14(3):E26–9.CrossRefPubMedGoogle Scholar
  159. 159.
    McMahon DK, Dummer JS, Pasculle AW, Cassell G. Extragenital Mycoplasma hominis infections in adults. Am J Med. 1990;89(3):275–81.CrossRefPubMedGoogle Scholar
  160. 160.
    Gass R, Fisher J, Badesch D, Zamora M, Weinberg A, Melsness H, et al. Donor-to-host transmission of Mycoplasma hominis in lung allograft recipients. Clin Infect Dis. 1996;22(3):567–8.CrossRefPubMedGoogle Scholar
  161. 161.
    Vogel U, Luneberg E, Kuse ER, Neulinger AL, Frosch M. Extragenital Mycoplasma hominis infection in two liver transplant recipients. Clin Infect Dis. 1997;24(3):512–3.CrossRefPubMedGoogle Scholar
  162. 162.
    Rohner P, Schnyder I, Ninet B, Schrenzel J, Lew D, Ramla T, et al. Severe Mycoplasma hominis infections in two renal transplant patients. Eur J Clin Microbiol Infect Dis. 2004;23(3):203–4.CrossRefPubMedGoogle Scholar
  163. 163.
    Mitsani D, Nguyen MH, Silveira FP, Bermudez C, Toyoda Y, Pasculle AW, et al. Mycoplasma hominis pericarditis in a lung transplant recipient: review of the literature about an uncommon but important cardiothoracic pathogen. Transpl Infect Dis. 2010;12(2):146–50.CrossRefPubMedGoogle Scholar
  164. 164.
    Burdge DR, Reid GD, Reeve CE, Robertson JA, Stemke GW, Bowie WR. Septic arthritis due to dual infection with Mycoplasma hominis and Ureaplasma urealyticum. J Rheumatol. 1988;15(2):366–8.PubMedGoogle Scholar
  165. 165.
    Haller M, Forst H, Ruckdeschel G, Denecke H, Peter K. Peritonitis due to Mycoplasma hominis and Ureaplasma urealyticum in a liver transplant recipient. Eur J Clin Microbiol Infect Dis. 1991;10(3):172.CrossRefPubMedGoogle Scholar
  166. 166.
    Lyon GM, Alspaugh JA, Meredith FT, Harrell LJ, Tapson V, Davis RD, et al. Mycoplasma hominis pneumonia complicating bilateral lung transplantation: case report and review of the literature. Chest. 1997;112(5):1428–32.CrossRefPubMedGoogle Scholar
  167. 167.
    Steffenson DO, Dummer JS, Granick MS, Pasculle AW, Griffith BP, Cassell GH. Sternotomy infections with Mycoplasma hominis. Ann Intern Med. 1987;106(2):204–8.CrossRefPubMedGoogle Scholar
  168. 168.
    Hopkins PM, Winlaw DS, Chhajed PN, Harkness JL, Horton MD, Keogh AM, et al. Mycoplasma hominis infection in heart and lung transplantation. J Heart Lung Transplant. 2002;21(11):1225–9.CrossRefPubMedGoogle Scholar
  169. 169.
    Pastural M, Audard V, Bralet MP, Remy P, Salomon L, Tankovic J, et al. Mycoplasma hominis infection in renal transplantation. Nephrol Dial Transplant. 2002;17(3):495–6.CrossRefPubMedGoogle Scholar
  170. 170.
    Kane JR, Shenep JL, Krance RA, Hurwitz CA. Diffuse alveolar hemorrhage associated with Mycoplasma hominis respiratory tract infection in a bone marrow transplant recipient. Chest. 1994;105(6):1891–2.CrossRefPubMedGoogle Scholar
  171. 171.
    Morozumi M, Takahashi T, Ubukata K. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J Infect Chemother. 2010;16(2):78–86.CrossRefPubMedGoogle Scholar
  172. 172.
    Redelinghuys MJ, Ehlers MM, Dreyer AW, Lombaard HA, Kock MM. Antimicrobial susceptibility patterns of Ureaplasma species and Mycoplasma hominis in pregnant women. BMC Infect Dis. 2014;14:171.PubMedCentralCrossRefPubMedGoogle Scholar
  173. 173.
    Samra Z, Rosenberg S, Dan M. Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin. J Chemother. 2011;23(2):77–9.CrossRefPubMedGoogle Scholar
  174. 174.
    Bove JR. Transfusion-transmitted diseases: current problems and challenges. Prog Hematol. 1986;14:123–47.PubMedGoogle Scholar
  175. 175.
    Tariciotti L, Das I, Dori L, Perera MT, Bramhall SR. Asymptomatic transmission of Treponema pallidum (syphilis) through deceased donor liver transplantation. Transpl Infect Dis. 2012;14(3):321–5.CrossRefPubMedGoogle Scholar
  176. 176.
    Steinmann J, Marggraf G, Buer J, Rath PM. Syphilis-specific immunoglobulin G seroconversion after double-lung transplantation. J Heart Lung Transplant. 2009;28(8):857–9.CrossRefPubMedGoogle Scholar
  177. 177.
    Cortes NJ, Afzali B, MacLean D, Goldsmith DJ, O’Sullivan H, Bingham J, et al. Transmission of syphilis by solid organ transplantation. Am J Transplant. 2006;6(10):2497–9.CrossRefPubMedGoogle Scholar
  178. 178.
    Naohara T, Suzuki G, Masauzi N, Ohizumi H, Kobayashi N, Ogasawara M, et al. Positive seroconversion syphilis in a patient with acute lymphocytic leukemia after allogeneic bone marrow transplantation. Rinsho Ketsueki. 1997;38(3):228–30.PubMedGoogle Scholar
  179. 179.
    Wolf SC, Kempf VA, Tannapfel A, Petersen P, Risler T, Brehm BR. Secondary syphilis after liver transplantation: case report and review of the literature. Clin Transplant. 2006;20(5):644–9.CrossRefPubMedGoogle Scholar
  180. 180.
    Farr M, Rubin AI, Mangurian C, Scully B, Silvers DN, Husain S, et al. Late syphilis in a cardiac transplant patient. J Heart Lung Transplant. 2006;25(3):358–61.CrossRefPubMedGoogle Scholar
  181. 181.
    Marty CL, Snow JL. Secondary syphilis in an immunocompromised kidney transplant recipient. Cutis. 2011;88(6):284–9.PubMedGoogle Scholar
  182. 182.
    Assi MA, Yao JD, Walker RC. Lyme disease followed by human granulocytic anaplasmosis in a kidney transplant recipient. Transpl Infect Dis. 2007;9(1):66–72.CrossRefPubMedGoogle Scholar
  183. 183.
    Habedank D, Hummel M, Musci M, Ruhlke A, Hetzer R. Lyme carditis 11 years after heart transplantation: a case report. Transplantation. 2003;75(12):2156–7.CrossRefPubMedGoogle Scholar
  184. 184.
    Maraspin V, Cimperman J, Lotric-Furlan S, Logar M, Ruzic-Sabljic E, Strle F. Erythema migrans in solid-organ transplant recipients. Clin Infect Dis. 2006;42(12):1751–4.CrossRefPubMedGoogle Scholar
  185. 185.
    Rodriguez M, Chou S, Fisher DC, De Girolami U, Amato AA, Marty FM. Lyme meningoradiculitis and myositis after allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2005;41(12):e112–4.CrossRefPubMedGoogle Scholar
  186. 186.
    Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43(9):1089–134.CrossRefPubMedGoogle Scholar
  187. 187.
    Heard SR, Ronalds CJ, Heath RB. Coxiella burnetii infection in immunocompromised patients. J Infect. 1985;11(1):15–8.CrossRefPubMedGoogle Scholar
  188. 188.
    Kanfer E, Farrag N, Price C, MacDonald D, Coleman J, Barrett AJ. Q fever following bone marrow transplantation. Bone Marrow Transplant. 1988;3(2):165–6.PubMedGoogle Scholar
  189. 189.
    Loudon MM, Thompson EN. Severe combined immunodeficiency syndrome, tissue transplant, leukaemia, and Q fever. Arch Dis Child. 1988;63(2):207–9.PubMedCentralCrossRefPubMedGoogle Scholar
  190. 190.
    Larsen CP, Bell JM, Ketel BL, Walker PD. Infection in renal transplantation: a case of acute Q fever. Am J Kidney Dis. 2006;48(2):321–6.CrossRefPubMedGoogle Scholar
  191. 191.
    Godinho I, Nogueira EL, Santos CM, Paulo SE, Fortes A, Guerra JO, et al. Chronic Q fever in a renal transplant recipient: a case report. Transplant Proc. 2015;47(4):1045–7.CrossRefPubMedGoogle Scholar
  192. 192.
    Rallis TM, Kriesel JD, Dumler JS, Wagoner LE, Wright ED, Spruance SL. Rocky Mountain spotted fever following cardiac transplantation. West J Med. 1993;158(6):625–8.PubMedCentralPubMedGoogle Scholar
  193. 193.
    Schmulewitz L, Moumile K, Patey-Mariaud de Serre N, Poiree S, Gouin E, Mechai F, et al. Splenic rupture and malignant Mediterranean spotted fever. Emerg Infect Dis. 2008;14(6):995–7.PubMedCentralCrossRefPubMedGoogle Scholar
  194. 194.
    Barrio J, de Diego A, Ripoll C, Perez-Calle JL, Nunez O, Salcedo M, et al. Mediterranean spotted fever in liver transplantation: a case report. Transplant Proc. 2002;34(4):1255–6.CrossRefPubMedGoogle Scholar
  195. 195.
    Phatharodom P, Limsrichamrern S, Kaewwinud J, Chayakulkeeree M. Murine typhus in a liver transplant recipient: report of a first case. Transpl Infect Dis. 2015;17(4):574–8.CrossRefPubMedGoogle Scholar
  196. 196.
    Blanton LS, Vohra RF, Bouyer DH, Walker DH. Reemergence of murine typhus in Galveston, Texas, USA, 2013. Emerg Infect Dis. 2015;21(3):484–6.PubMedCentralCrossRefPubMedGoogle Scholar
  197. 197.
    Antony SJ, Dummer JS, Hunter E. Human ehrlichiosis in a liver transplant recipient. Transplantation. 1995;60(8):879–81.CrossRefPubMedGoogle Scholar
  198. 198.
    Adachi JA, Grimm EM, Johnson P, Uthman M, Kaplan B, Rakita RM. Human granulocytic ehrlichiosis in a renal transplant patient: case report and review of the literature. Transplantation. 1997;64(8):1139–42.CrossRefPubMedGoogle Scholar
  199. 199.
    Buller RS, Arens M, Hmiel SP, Paddock CD, Sumner JW, Rikhisa Y, et al. Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis. N Engl J Med. 1999;341(3):148–55.CrossRefPubMedGoogle Scholar
  200. 200.
    Thomas LD, Hongo I, Bloch KC, Tang YW, Dummer S. Human ehrlichiosis in transplant recipients. Am J Transplant. 2007;7(6):1641–7.CrossRefPubMedGoogle Scholar
  201. 201.
    Paddock CD, Folk SM, Shore GM, Machado LJ, Huycke MM, Slater LN, et al. Infections with Ehrlichia chaffeensis and Ehrlichia ewingii in persons coinfected with human immunodeficiency virus. Clin Infect Dis. 2001;33(9):1586–94.CrossRefPubMedGoogle Scholar
  202. 202.
    Safdar N, Love RB, Maki DG. Severe Ehrlichia chaffeensis infection in a lung transplant recipient: a review of ehrlichiosis in the immunocompromised patient. Emerg Infect Dis. 2002;8(3):320–3.PubMedCentralCrossRefPubMedGoogle Scholar
  203. 203.
    Sachdev SH, Joshi V, Cox ER, Amoroso A, Palekar S. Severe life-threatening Ehrlichia chaffeensis infections transmitted through solid organ transplantation. Transpl Infect Dis. 2014;16(1):119–24.CrossRefPubMedGoogle Scholar
  204. 204.
    Olano JP, Walker DH. Human ehrlichioses. Med Clin North Am. 2002;86(2):375–92.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Open Access This chapter is distributed under the terms of the Creative Commons Attribution Noncommercial License, which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Authors and Affiliations

  1. 1.Department of Medicine, Division of Infectious DiseasesOregon Health and Science UniversityPortlandUSA
  2. 2.Department of Medicine and Surgery, Transplant Infectious DiseasesVanderbilt University School of MedicineNashvilleUSA

Personalised recommendations